Pulmonary hypertension in pregnancy

Cardiology in Review

Volumn 21, Issue 4, 2013, Pages 167-173

  Martínez, Mariella Vélez ^a   Rutherford, John D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Eisenmenger syndrome; pregnancy; prostacyclin; pulmonary hypertension

Indexed keywords

AMBRISENTAN; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; DOPAMINE; ENDOTHELIN 1; ENOXAPARIN; FUROSEMIDE; HEPARIN; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; NIFEDIPINE; NITRIC OXIDE; PHENYLEPHRINE; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SILDENAFIL; SPIRONOLACTONE; WARFARIN;

CESAREAN SECTION; CONTRACEPTION; DELIVERY; EARLY DIAGNOSIS; EISENMENGER COMPLEX; ENDOTRACHEAL INTUBATION; EPIDURAL ANESTHESIA; GENERAL ANESTHESIA; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MATERNAL MORTALITY; OXYGEN CONSUMPTION; OXYGEN THERAPY; PERINATAL PERIOD; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; SURVIVAL;

CESAREAN SECTION; EPOPROSTENOL; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RISK FACTORS; SURVIVAL RATE;

EID: 84880133214     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318275cf01     Document Type: Review

References (62)

1. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115:343-349.
2. Tuder RM, Marecki JC, Richter A, et al. Pathology of pulmonary hypertension. Clin Chest Med. 2007;28:23-42, vii.
3. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S43-S54.
4. Dawkins KD, Burke CM, Billingham ME, et al. Primary pulmonary hypertension and pregnancy. Chest. 1986;89:383-388.
5. Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761-81.
6. Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009;30:256-265.
7. Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol. 2007;120:198-204.
8. Weiss BM, Zemp L, Seifert B, et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31:1650-1657.
9. Robson SC, Hunter S, Moore M, et al. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol. 1987;94:1028-1039.
10. Beghetti M, Galiè N. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;53:733-740.
11. Hopkins WE. The remarkable right ventricle of patients with Eisenmenger syndrome. Coron Artery Dis. 2005;16:19-25.
12. Makaryus AN, Forouzesh A, Johnson M. Pregnancy in the patient with Eisenmenger's syndrome. Mt Sinai J Med. 2006;73:1033-1036.
13. Thorne S, Nelson-Piercy C, MacGregor A, et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care. 2006;32:75-81.
14. Robson SC, Dunlop W, Boys RJ, et al. Cardiac output during labour. Br Med J (Clin Res Ed). 1987;295:1169-1172.
15. Famuyide AO, Hopkins MR, El-Nashar SA, et al. Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center. Mayo Clin Proc. 2008;83:431-438.
16. Hemnes AR, Robbins IM. Hysteroscopic sterilization in women with pulmonary vascular disease. Mayo Clin Proc. 2008;83:1188-9; author reply 1189.
17. Kiely DG, Condliffe R, Webster V, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG. 2010;117:565-574.
18. Naqvi TZ, Foster E. Anticoagulation during pregnancy. Curr Womens Health Rep. 2002;2:95-104.
19. Pitts JA, Crosby WM, Basta LL. Eisenmenger's syndrome in pregnancy: does heparin prophylaxis improve the maternal mortality rate? Am Heart J. 1977;93:321-326.
20. Easterling TR, Benedetti TJ, Carlson KL, et al. Measurement of cardiac output in pregnancy by thermodilution and impedance techniques. Br J Obstet Gynaecol. 1989;96:67-69.
21. Hecker A, Hasan SH, Neumann F. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinol. 1980;95:540-545.
22. Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation. 1999;99:1858-1865.
23. McLaughlin VV, Genthner DE, Panella MM, et al. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. Ann Intern Med. 1999;130:740-743.
24. Avdalovic M, Sandrock C, Hoso A, et al. Epoprostenol in pregnant patients with secondary pulmonary hypertension: two case reports and a review of the literature. Treat Respir Med. 2004;3:29-34.
25. Badalian SS, Silverman RK, Aubry RH, et al. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report. J Reprod Med. 2000;45:149-152.
26. Bendayan D, Hod M, Oron G, et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol. 2005;106(5 Pt 2):1206-1210.
27. Bildirici I, Shumway JB. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery. Obstet Gynecol. 2004;103(5 Pt 2):1102-1105.
28. Cotrim SC, Loureiro MJ, Avillez T, et al. Three cases of pregnancy in patients with severe pulmonary arterial hypertension: experience of a single unit. Rev Port Cardiol. 2010;29:95-103.
29. Easterling TR, Ralph DD, Schmucker BC. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol. 1999;93:494-498.
30. Elliot CA, Stewart P, Webster VJ, et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J. 2005;26:168-173.
31. Garabedian MJ, Hansen WF, Gianferrari EA, et al. Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy. J Perinatol. 2010;30:628-631.
32. Goland S, Tsai F, Habib M, et al. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension. Cardiology. 2010;115:205-208.
33. Higton AM, Whale C, Musk M, et al. Pulmonary hypertension in pregnancy: two cases and review of the literature. Intern Med J. 2009;39:766-770.
34. Nahapetian A, Oudiz RJ. Serial hemodynamics and complications of pregnancy in severe pulmonary arterial hypertension. Cardiology. 2008;109:237-240.
35. O'Hare R, McLoughlin C, Milligan K, et al. Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension. Br J Anaesth. 1998;81:790-792.
36. Stewart R, Tuazon D, Olson G, et al. Pregnancy and primary pulmonary hypertension: successful outcome with epoprostenol therapy. Chest. 2001;119:973-975.
37. Weiss BM, Maggiorini M, Jenni R, et al. Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology. 2000;92:1191-1194.
38. Wong PS, Constantinides S, Kanellopoulos V, et al. Primary pulmonary hypertension in pregnancy. J R Soc Med. 2001;94:523-525.
39. Ishikawa S, Miyauchi T, Sakai S, et al. Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair. J Thorac Cardiovasc Surg. 1995;110:271-273.
40. Kenyon KW, Nappi JM. Bosentan for the treatment of pulmonary arterial hypertension. Ann Pharmacother. 2003;37:1055-1062.
41. Kothari SS, Duggal B. Chronic oral sildenafil therapy in severe pulmonary artery hypertension. Indian Heart J. 2002;54:404-409.
42. Michelakis ED. The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension. Heart Fail Rev. 2003;8:5-21.
43. Michelakis ED, Tymchak W, Noga M, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation. 2003;108:2066-2069.
44. Mukhopadhyay S, Sharma M, Ramakrishnan S, et al. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Circulation. 2006;114:1807-1810.
45. Sitbon O, Humbert M, Jaïs X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111:3105-3111.
46. Magee LA, Schick B, Donnenfeld AE, et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol. 1996;174:823-828.
47. Smedstad KG, Cramb R, Morison DH. Pulmonary hypertension and pregnancy: a series of eight cases. Can J Anaesth. 1994;41:502-512.
48. Decoene C, Bourzoufi K, Moreau D, et al. Use of inhaled nitric oxide for emergency Cesarean section in a woman with unexpected primary pulmonary hypertension. Can J Anaesth. 2001;48:584-587.
49. Lam GK, Stafford RE, Thorp J, et al. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol. 2001;98(5 Pt 2):895-898.
50. Blaise G, Langleben D, Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology. 2003;99:1415-1432.
51. Martin JT, Tautz TJ, Antognini JF. Safety of regional anesthesia in Eisenmenger's syndrome. Reg Anesth Pain Med. 2002;27:509-513.
52. Bonnin M, Mercier FJ, Sitbon O, et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology. 2005;102:1133-7; discussion 5A.
53. Roberts NV, Keast PJ. Pulmonary hypertension and pregnancy-a lethal combination. Anaesth Intensive Care. 1990;18:366-374.
54. Evora PR, Pearson PJ, Schaff HV. Arginine vasopressin induces endotheliumdependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest. 1993;103:1241-1245.
55. Price LC, Forrest P, Sodhi V, et al. Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth. 2007;99:552-555.
56. Weiss BM, Hess OM. Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J. 2000;21:104-115.
57. Sitbon O, McLaughlin VV, Badesch DB, et al. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Thorax. 2005;60:1025-1030.
58. Curran WD, Akindipe O, Staples ED, et al. Lung transplantation for primary pulmonary hypertension and Eisenmenger's syndrome. J Cardiovasc Nurs. 2005;20:124-132.
59. Conte JV, Borja MJ, Patel CB, et al. Lung transplantation for primary and secondary pulmonary hypertension. Ann Thorac Surg. 2001;72:1673-9; discussion 1679.
60. Toyoda Y, Thacker J, Santos R, et al. Long-term outcome of lung and heartlung transplantation for idiopathic pulmonary arterial hypertension. Ann Thorac Surg. 2008;86:1116-1122.
61. Trulock EP, Edwards LB, Taylor DO, et al.; International Society for Heart and Lung Transplantation. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 2006; 25:880-892.
62. Franke U, Wiebe K, Harringer W, et al. Ten years experience with lung and heart-lung transplantation in primary and secondary pulmonary hypertension. Eur J Cardiothorac Surg. 2000;18:447-452.